PureTech Health (PRTC) Total Non-Current Liabilities (2019 - 2025)

PureTech Health (PRTC) reported Total Non-Current Liabilities of $182.7 million for Q4 2025, up 19.18% year-over-year from $153.3 million in Q4 2024, and up 27.21% on a QoQ basis from $143.6 million in Q2 2025.

PureTech Health (PRTC) has 7 years of Total Non-Current Liabilities data on file, last reported at $182.7 million in Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 19.18% year-over-year to $182.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $182.7 million (up 19.18% YoY) and the FY2025 annual result came in at $182.7 million, up 19.18% from the prior year.
  • Total Non-Current Liabilities grew to $182.7 million in Q4 2025 per PRTC's latest filing, from $143.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $182.7 million in Q4 2025 and bottomed at -$3.5 million in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $139.7 million (2021), against an average of $111.7 million.
  • The widest annual swing landed in 2023, when Total Non-Current Liabilities plunged 106.02%; it then jumped 4479.15% in 2024.
  • Tracing PRTC's Total Non-Current Liabilities over 5 years: stood at $135.7 million in 2021, then tumbled by 57.14% to $58.2 million in 2022, then sank by 106.02% to -$3.5 million in 2023, then jumped by 4479.15% to $153.3 million in 2024, then rose by 19.18% to $182.7 million in 2025.
  • Per Business Quant, the three latest PRTC Total Non-Current Liabilities figures stand at $182.7 million (Q4 2025), $143.6 million (Q2 2025), and $153.3 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 11.03 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 42,980.09
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 110.28 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 5.87 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 7.32 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.05 Bn
10 PureTech Health 86.36 Mn -190.94 Mn - 182.73 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 182.73 Mn
Jun 30, 2025 143.64 Mn
Dec 31, 2024 153.31 Mn
Dec 31, 2023 -3.50 Mn
Dec 31, 2022 58.17 Mn
Dec 31, 2021 135.73 Mn
Dec 31, 2020 155.53 Mn
Dec 31, 2019 151.58 Mn